141 related articles for article (PubMed ID: 33094790)
21. Structures of the human Wilson disease copper transporter ATP7B.
Yang GM; Xu L; Wang RM; Tao X; Zheng ZW; Chang S; Ma D; Zhao C; Dong Y; Wu S; Guo J; Wu ZY
Cell Rep; 2023 May; 42(5):112417. PubMed ID: 37074913
[TBL] [Abstract][Full Text] [Related]
22. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
23. NMR characterization of copper-binding domains 4-6 of ATP7B .
Fatemi N; Korzhnev DM; Velyvis A; Sarkar B; Forman-Kay JD
Biochemistry; 2010 Oct; 49(39):8468-77. PubMed ID: 20799727
[TBL] [Abstract][Full Text] [Related]
24. Binding of copper(I) by the Wilson disease protein and its copper chaperone.
Wernimont AK; Yatsunyk LA; Rosenzweig AC
J Biol Chem; 2004 Mar; 279(13):12269-76. PubMed ID: 14709553
[TBL] [Abstract][Full Text] [Related]
25. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
26. Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
Cater MA; La Fontaine S; Mercer JF
Biochem J; 2007 Jan; 401(1):143-53. PubMed ID: 16939419
[TBL] [Abstract][Full Text] [Related]
27. Copper-dependent interaction of dynactin subunit p62 with the N terminus of ATP7B but not ATP7A.
Lim CM; Cater MA; Mercer JF; La Fontaine S
J Biol Chem; 2006 May; 281(20):14006-14. PubMed ID: 16554302
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY
Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
[TBL] [Abstract][Full Text] [Related]
29. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
[TBL] [Abstract][Full Text] [Related]
31. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
32. Disease-causing point-mutations in metal-binding domains of Wilson disease protein decrease stability and increase structural dynamics.
Kumar R; Ariöz C; Li Y; Bosaeus N; Rocha S; Wittung-Stafshede P
Biometals; 2017 Feb; 30(1):27-35. PubMed ID: 27744583
[TBL] [Abstract][Full Text] [Related]
33. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population.
Allocca S; Ciano M; Ciardulli MC; D'Ambrosio C; Scaloni A; Sarnataro D; Caporaso MG; D'Agostino M; Bonatti S
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954118
[TBL] [Abstract][Full Text] [Related]
34. COMMD1 and PtdIns(4,5)P
Stewart DJ; Short KK; Maniaci BN; Burkhead JL
J Cell Sci; 2019 Oct; 132(19):. PubMed ID: 31515276
[TBL] [Abstract][Full Text] [Related]
35. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.
Leonhardt K; Gebhardt R; Mössner J; Lutsenko S; Huster D
J Biol Chem; 2009 Mar; 284(12):7793-802. PubMed ID: 19141620
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
37. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.
Lutsenko S; Tsivkovskii R; Walker JM
Ann N Y Acad Sci; 2003 Apr; 986():204-11. PubMed ID: 12763797
[TBL] [Abstract][Full Text] [Related]
38. Communication between the N and C termini is required for copper-stimulated Ser/Thr phosphorylation of Cu(I)-ATPase (ATP7B).
Braiterman LT; Gupta A; Chaerkady R; Cole RN; Hubbard AL
J Biol Chem; 2015 Apr; 290(14):8803-19. PubMed ID: 25666620
[TBL] [Abstract][Full Text] [Related]
39. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity.
Walker JM; Tsivkovskii R; Lutsenko S
J Biol Chem; 2002 Aug; 277(31):27953-9. PubMed ID: 12029094
[TBL] [Abstract][Full Text] [Related]
40. The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation.
Bartee MY; Ralle M; Lutsenko S
Biochemistry; 2009 Jun; 48(24):5573-81. PubMed ID: 19405516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
